Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |